US FDA approves first drug to slow progression of Alzheimer’s disease, opens door for Medicare to pay
By Melissa Patrick Kentucky Health News The U.S. Food and Drug Administration has granted full approval for the first drug to slow…
Alzheimer’s drug
Read More
Joe Cotton: Stock of the week is the very speculative Cassava Sciences, in third phase of Alzheimer’s trials
Market Assessment – As of Wednesday, August 24 at 12:11 p.m. The Market (The DOW) is now up about 158…